News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
642,621 Results
Type
Article (61212)
Company Profile (74)
Press Release (581335)
Section
Business (173656)
Career Advice (2729)
Deals (32417)
Drug Delivery (96)
Drug Development (76794)
Employer Resources (151)
FDA (14920)
Job Trends (13888)
News (304813)
Policy (28969)
Tag
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (1)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (9)
2024 Biotech Beach Digital (3)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (3)
2025 Lone Star Bio Digital (2)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Pharm Country Premier (1)
Academia (2886)
Academic (2)
Accelerated approval (3)
Adcomms (22)
Allergies (83)
Alliances (43085)
ALS (82)
Alzheimer's disease (1296)
Antibody-drug conjugate (ADC) (94)
Approvals (14933)
Artificial intelligence (238)
Autoimmune disease (18)
Automation (13)
Bankruptcy (290)
Best Places to Work (10857)
BIOSECURE Act (15)
Biosimilars (98)
Biotechnology (54)
Bladder cancer (61)
Brain cancer (25)
Breast cancer (247)
Cancer (1934)
Cardiovascular disease (153)
Career advice (2308)
Career pathing (32)
CAR-T (142)
Cell therapy (398)
Cervical cancer (20)
Clinical research (62211)
Collaboration (720)
Compensation (277)
Complete response letters (20)
COVID-19 (2566)
CRISPR (38)
C-suite (228)
Cystic fibrosis (98)
Data (1917)
Decentralized trials (2)
Denatured (25)
Depression (38)
Diabetes (233)
Diagnostics (6123)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (39)
Drug discovery (105)
Drug pricing (95)
Drug shortages (23)
Duchenne muscular dystrophy (78)
Earnings (59759)
Editorial (33)
Employer branding (18)
Employer resources (133)
Events (93758)
Executive appointments (677)
FDA (16026)
Featured Employer (26)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (688)
Gene editing (100)
Generative AI (19)
Gene therapy (270)
GLP-1 (641)
Government (4429)
Grass and pollen (5)
Guidances (45)
Healthcare (18206)
Huntington's disease (18)
IgA nephropathy (20)
Immunology and inflammation (96)
Indications (25)
Infectious disease (2688)
Inflammatory bowel disease (131)
Inflation Reduction Act (8)
Influenza (49)
Intellectual property (86)
Interviews (526)
IPO (14765)
IRA (38)
Job creations (3429)
Job search strategy (1943)
Kidney cancer (9)
Labor market (26)
Layoffs (485)
Leadership (18)
Legal (6474)
Liver cancer (64)
Lung cancer (278)
Lymphoma (126)
Machine learning (4)
Management (53)
Manufacturing (243)
MASH (56)
Medical device (12645)
Medtech (12650)
Mergers & acquisitions (18164)
Metabolic disorders (582)
Multiple sclerosis (68)
NASH (13)
Neurodegenerative disease (76)
Neuropsychiatric disorders (23)
Neuroscience (1756)
NextGen: Class of 2025 (6382)
Non-profit (4326)
Northern California (2188)
Now hiring (11)
Obesity (299)
Opinion (227)
Ovarian cancer (68)
Pain (83)
Pancreatic cancer (73)
Parkinson's disease (126)
Partnered (20)
Patents (204)
Patient recruitment (94)
Peanut (50)
People (59349)
Pharmaceutical (21)
Pharmacy benefit managers (15)
Phase I (19571)
Phase II (27452)
Phase III (20054)
Pipeline (985)
Podcasts (55)
Policy (101)
Postmarket research (2469)
Preclinical (8304)
Press Release (67)
Prostate cancer (93)
Psychedelics (27)
Radiopharmaceuticals (247)
Rare diseases (339)
Real estate (5989)
Recruiting (62)
Regulatory (19973)
Reports (33)
Research institute (2394)
Resumes & cover letters (405)
Rett syndrome (3)
RNA editing (3)
RSV (33)
Schizophrenia (63)
Series A (121)
Series B (80)
Service/supplier (9)
Sickle cell disease (50)
Southern California (1940)
Special edition (10)
Spinal muscular atrophy (146)
Sponsored (28)
Startups (3344)
State (1)
Stomach cancer (9)
Supply chain (46)
The Weekly (28)
United States (19472)
Vaccines (632)
Venture capitalists (29)
Webinars (12)
Weight loss (192)
Women's health (30)
Worklife (17)
Date
Today (143)
Last 7 days (707)
Last 30 days (2666)
Last 365 days (31098)
2025 (7699)
2024 (32284)
2023 (36360)
2022 (46637)
2021 (51573)
2020 (50737)
2019 (44813)
2018 (34090)
2017 (30733)
2016 (30095)
2015 (35472)
2014 (28406)
2013 (24992)
2012 (26255)
2011 (26490)
2010 (24957)
Location
Africa (873)
Alabama (50)
Alaska (6)
Arizona (167)
Arkansas (14)
Asia (37934)
Australia (6836)
California (5010)
Canada (1709)
China (438)
Colorado (229)
Connecticut (242)
Delaware (123)
Europe (88154)
Florida (768)
Georgia (188)
Idaho (56)
Illinois (509)
India (23)
Indiana (264)
Iowa (8)
Japan (132)
Kansas (91)
Kentucky (23)
Louisiana (7)
Maine (59)
Maryland (776)
Massachusetts (3656)
Michigan (210)
Minnesota (325)
Mississippi (2)
Missouri (82)
Montana (29)
Nebraska (23)
Nevada (51)
New Hampshire (61)
New Jersey (1504)
New Mexico (29)
New York (1479)
North Carolina (913)
North Dakota (8)
Northern California (2188)
Ohio (181)
Oklahoma (15)
Oregon (35)
Pennsylvania (1122)
Puerto Rico (10)
Rhode Island (24)
South America (1178)
South Carolina (15)
South Dakota (1)
Southern California (1940)
Tennessee (88)
Texas (774)
Utah (157)
Virginia (128)
Washington D.C. (46)
Washington State (474)
West Virginia (3)
Wisconsin (53)
642,621 Results for "university of minnesota".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
FDA Clears Investigational New Drug application for muscular dystrophy treatment from University of Minnesota startup Myogenica
July 17, 2024
·
2 min read
Business
TOPIX Pharmaceuticals, Inc. Partners with the University of Minnesota, Center for Drug Design to Develop Groundbreaking ProteXidine Molecule
According to the Skin Cancer Foundation, 90% of skin aging is caused by the sun,1 and even with proper SPF usage, harmful UV rays can still penetrate the skin.
June 5, 2024
·
4 min read
Drug Development
Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation Human Data Readout for Phase 1 Study to Evaluate HCW9218 in Solid Tumors at SITC 38th Annual Meeting
HCW Biologics Inc. will have a human data readout at the 38th Annual Meeting of the Society for Immunotherapy of Cancer from an ongoing Phase 1 clinical trial to evaluate HCW9218 in patients with chemo-refractory/chemo-resistant solid tumors, conducted by the Masonic Cancer Center, University of Minnesota.
November 1, 2023
·
5 min read
Press Releases
Zomedica Completes Renovation & Upgrade of Manufacturing, Distribution, and R&D Center in Plymouth, Minnesota
September 11, 2024
·
7 min read
BioMidwest
Nura Pain Clinics Physician Treats First Patient in Minnesota with New Medtronic SynchroMed III Targeted Drug Delivery System for Pain
Nura Pain Clinics, the Twin Cities’ foremost multidisciplinary pain management clinic, announced today that the first patient in Minnesota has been implanted with the new Medtronic SynchroMed™ III implantable drug pump for the treatment of chronic pain.
January 9, 2024
·
5 min read
BioForest
Immusoft Acquires Exclusive, Worldwide Rights to Intellectual Property for Genome Edited Primary B Cells from the University of Minnesota
Immusoft today announced that it has successfully closed a license with the Regents of the University of Minnesota for the exclusive, worldwide rights to intellectual property (IP) for compositions of matter and methods to make and use genome edited primary B cells.
March 27, 2023
·
2 min read
BioMidwest
Inspired Spine Unveils two Centers of Excellence for High BMI Patients in Rural Minnesota and Kansas
Inspired Spine has announced the establishment of two new Centers of Excellence focused on providing complex spine care, including fusion surgeries, to patients with high Body Mass Index in rural areas of Minnesota and Kansas, a groundbreaking turn in modern spine health management.
November 29, 2023
·
3 min read
BioMidwest
SynerFuse™ Announces IDE Proof of Concept Study Data Presented at Minnesota Neuromodulation Symposium
Justin Zenanko, CEO of SynerFuse™, is proud to announce that Michael Park, M.D., associate professor of neurosurgery at the University of Minnesota, SynerFuse IDE Proof of Concept study PI, presented data from the Proof of Concept study’s first eight patients at the 10th annual Minnesota Neuromodulation Symposium, April 21, 2023.
April 24, 2023
·
3 min read
ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University
Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.
March 11, 2024
·
3 min read
Business
Inceptor Bio Announces Strategic Collaboration with University of Minnesota to Develop Novel iPSC Platform for the Advancement of Next-Generation Allogeneic Cell Therapies
Inceptor Bio, a biotechnology company advancing cell therapies for difficult-to-treat cancers, today announced a collaboration with University of Minnesota.
June 30, 2022
·
2 min read
1 of 64,263
Next